Cardioselective beta-blockers for chronic obstructive pulmonary disease.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2005-10-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD003566.PUB2PMID 12076486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Beta1-blocker (practolol) and exercise in patients with chronic obstructive lung disease.

  2009cited by this paper
• Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.

  2004cited by this paper
• Dose-response relationship of the β-adrenoceptor antagonist bisoprolol in patients with coronary heart disease and chronic obstructive bronchitis

  2004cited by this paper
• Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease.

  2004cited by this paper
• Respiratory function in the elderly and the effects of beta blockade

  2004cited by this paper
• Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris

  2004cited by this paper
• Influence of cardioselectivity and respiratory disease on pulmonary responsiveness to beta-blockade

  2004cited by this paper
• Required beta blocker profile in the elderly

  2004cited by this paper
• Metoprolol, a Β-1 selective blocker, can be used safely in coronary artery disease patients with chronic obstructive pulmonary disease

  2003cited by this paper
• Cardioselective beta-blockers for reversible airway disease.

  2002cited by this paper
• Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma.

  2001cited by this paper
• Long-term effect of atenolol on ejection fraction, symptoms, and exercise variables in patients with advanced left ventricular dysfunction.

  2001cited by this paper
• Changes in rates of β-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction

  2000cited by this paper
• Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.

  2000cited by this paper
• Improvement of exercise capacity and left ventricular diastolic function with metoprolol XL after acute myocardial infarction.

  2000cited by this paper
• Beta-Blockers after Myocardial Infarction: Do Benefits Ever Outweigh Risks in Asthma?

  2000cited by this paper
• Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction.

  2000cited by this paper
• Meta-analysis of Trials Comparing β-Blockers, Calcium Antagonists, and Nitrates for Stable Angina

  1999cited by this paper
• Early -Blocker Therapy for Acute Myocardial Infarction in Elderly Patients

  1999cited by this paper
• Early beta-blocker therapy for acute myocardial infarction in elderly patients.

  1999cited by this paper
• β Blockade after myocardial infarction: systematic review and meta regression analysis

  1999cited by this paper
• beta Blockade after myocardial infarction: systematic review and meta regression analysis.

  1999cited by this paper
• Pooling research results: benefits and limitations of meta-analysis.

  1999cited by this paper
• Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials.

  1998cited by this paper
• National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.

  1998cited by this paper
• Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction.

  1998cited by this paper
• National patterns and predictors of beta-blocker use in patients with coronary artery disease.

  1998cited by this paper
• Atenolol reduced mortality and cardiovascular events after noncardiac surgery

  1997cited by this paper
• The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

  1997cited by this paper
• Adverse Outcomes of Underuse of β-Blockers in Elderly Survivors of Acute Myocardial Infarction

  1997cited by this paper
• Clinical relevance of pharmacokinetic differences between beta blockers.

  1997cited by this paper
• Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials.

  1997cited by this paper
• Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group.

  1996cited by this paper
• Beta blockers prevent cardiac death following a myocardial infarction: so why are so many infarct survivors discharged without beta blockers?

  1996cited by this paper
• Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group.

  1996cited by this paper
• Problem drugs for the patient with asthma.

  1996cited by this paper
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society.

  1995cited by this paper
• Physician use of beta-adrenergic blocking therapy: a changing perspective.

  1995cited by this paper
• Safety of Esmolol in Patients with Acute Myocardial Infarction Treated with Thrombolytic Therapy Who Had Relative Contraindications to Beta-Blocker Therapy

  1994cited by this paper
• Treatment of Hyperthyroid Disease

  1994cited by this paper
• Beta blocker use in the treatment of community hospital patients discharged after myocardial infarction

  1994cited by this paper
• Beta-blockers and depression. Evidence against an association.

  1992cited by this paper
• Quality of life in treatment of hypertension. A metaanalysis of clinical trials.

  1992cited by this paper
• A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias.

  1992cited by this paper
• Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials.

  1991cited by this paper
• Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

  1991cited by this paper
• Newer beta blockers and the treatment of hypertension

  1991cited by this paper
• The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes

  1991cited by this paper
• Choice of drug treatment for elderly hypertensive patients.

  1991cited by this paper
• Effects of beta-blocking agents on insulin secretion and glucose disposal.

  1990cited by this paper
• Involvement of Protein Kinase C in the Regulation of Cortisol Production by Guinea Pig Adrenocortical Cells

  1990cited by this paper
• Diabetic patients and beta-blockers after acute myocardial infarction.

  1990cited by this paper
• Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease

  1990cited by this paper
• A comparison of statistical methods for combining event rates from clinical trials.

  1989cited by this paper
• Comparative effects of bisoprolol and acebutolol in smokers with airway obstruction.

  1988cited by this paper
• Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy.

  1987cited by this paper
• Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.

  1986cited by this paper
• Beta adrenoceptor antagonists and respiratory disease.

  1986cited by this paper
• A comparison of celiprolol and chlorthalidone in hypertensive patients with reversible bronchial obstruction.

  1986cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Beta adrenoceptor antagonists and respiratory disease.

  1986cited by this paper
• Respiratory effects of four adrenergic blocking agents combined with a diuretic in treating hypertension with concurrent chronic obstructive lung disease.

  1986cited by this paper
• The effects of treatments with labetalol and hydrochlorothiazide on ventilatory function of asthmatic hypertensive patients with demonstrated bronchosensitivity to propranolol.

  1985cited by this paper
• Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group.

  1985cited by this paper
• Ventilatory effects of long-term treatment with pindolol and metoprolol in hypertensive patients with chronic obstructive lung disease.

  1985cited by this paper
• Beta blockade during and after myocardial infarction: an overview of the randomized trials.

  1985cited by this paper
• Göteborg Metoprolol Trial: design, patient characteristics and conduct.

  1984cited by this paper
• Beta-adrenergic blockade for survivors of acute myocardial infarction.

  1984cited by this paper
• β-Adrenergic Blockade for Survivors of Acute Myocardial Infarction

  1984cited by this paper
• Dose-response relationship of the beta-adrenoceptor antagonist bisoprolol in patients with coronary heart disease and chronic obstructive bronchitis.

  1984cited by this paper
• Treatment of Hypertension in Mild Asthmatic Patients With Atenolol

  1984cited by this paper
• Pafenolol, a highly selective β1‐adrenoceptor–antagonist, in asthmatic patients: Interaction with terbutaline

  1983cited by this paper
• Effect of beta-adrenergic blockade on hyperventilation and exercise tolerance in emphysema.

  1983cited by this paper
• Suppression of Atrial Ectopy with Intravenous Metoprolol in Chronic Obstructive Pulmonary Disease Patients

  1983cited by this paper
• β-adrenoceptor Blockade and Pulmonary Function in Patients Suffering from Chronic Obstructive Lung Disease

  1983cited by this paper
• Effect of metoprolol on cardiac and pulmonary function in chronic obstructive pulmonary disease

  1983cited by this paper
• Effects of labetalol in hypertensive patients with chronic obstructive pulmonary disease.

  1983cited by this paper
• The effect of beta-blockers on ventilatory function in chronic bronchitis.

  1982cited by this paper
• Reversibility of bronchospasm in airway obstruction.

  1982cited by this paper
• Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.

  1982cited by this paper
• A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease.

  1982cited by this paper
• Reversibility of bronchospasm in airway obstruction.

  1982influential reference
• Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane.

  1981cited by this paper
• Adverse effect of propranolol on airway function in nonasthmatic chronic obstructive lung disease.

  1981cited by this paper
• Effect of intravenous metoprolol on reversible obstructive airways disease

  1981cited by this paper
• THE EFFECT OF OXPRENOLOL, ACEBUTOLOL AND PROPRANOLOL ON THYROID HORMONES IN HYPERTHYROID SUBJECTS

  1980cited by this paper
• A Comparison of Oral Metoprolol and Propranolol in Patients with Chronic Bronchitis

  1980cited by this paper
• Beta-adrenoceptor blockers and terbutaline in patients with chronic obstructive lung disease. Effects and interaction after oral administration.

  1980cited by this paper
• Comparison of effects of propranolol and metoprolol on airways obstruction in chronic bronchitis.

  1979influential reference
• Persistent asthma after treatment with beta-blocking drugs

  1979cited by this paper
• The effects of oral propranolol and metoprolol on lung function and exercise performance in chronic airways obstruction.

  1978cited by this paper
• Beta-blockers and asthma.

  1978cited by this paper
• Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction.

  1978cited by this paper
• Broncho-and cardioselective beta-receptor active drugs in the treatment of asthmatic patients. Clinical studies of effects and side effects of terbutaline, practolol and metoprolol.

  1977cited by this paper
• [Effects of a new cardioselective beta-adrenergic blocker (atenolol) on airway resistance in chronic obstructive disease (author's transl)].

  1977cited by this paper
• The effect of metoprolol and practolol on lung function and blood pressure in hypertensive asthmatics.

  1976cited by this paper
• Effects of muliple doses of metoprolol and propranolol on ventilatory function in patients with chronic obstructive lung disease.

  1976influential reference
• [Propranolol and pindolol in chronic obstructive lung disease (author's transl)].

  1976cited by this paper
• Effects of oxprenolol on the airways of normal and bronchitic subjects

  1976cited by this paper
• Use of beta-adrenoreceptor blockers in combination with beta-stimulators in patients with obstructive lung disease.

  1976cited by this paper

• Bisoprolol to prevent adverse cardiac events (PACE) in COPD: a multicentre, double-blind, randomised, controlled, phase 3 trial.

  2026cites this paper
• The Intersection of Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: Recent Insights in a Challenging Area

  2025cites this paper
• Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCT.

  2025cites this paper
• Unrecognized Actionable Cardiac Arrhythmias in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease: Can Continuous Monitoring Unmask the Culprit.

  2025cites this paper
• PERSONALIZING THE APPROACH FOR THE DIAGNOSIS OF PATIENTS WITH CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND HEART FAILURE.

  2025cites this paper
• Appraisal of β-Blocker Use in Patients with Cardiovascular Disease and Chronic Obstructive Pulmonary Disease

  2025cites this paper
• Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease.

  2024cites this paper
• ASSOCIATION OF BETA BLOCKER USE AND COPD MORTALITY: A SYSTEMATIC REVIEW

  2024cites this paper
• A Research Agenda to Improve Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: An Official American Thoracic Society Research Statement

  2024cites this paper
• Effects of the Use of Beta-Blockers on Chronic Obstructive Pulmonary Disease Associated with Cardiovascular Comorbities: Systematic Review and Meta-analysis

  2024cites this paper
• Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial.

  2024cites this paper
• Implementation of the Care Bundle for the Management of Chronic Obstructive Pulmonary Disease with/without Heart Failure

  2024cites this paper
• Prognostic impact of chronic obstructive pulmonary disease in patients with heart failure with mildly reduced ejection fraction.

  2024cites this paper
• Effect of chronic lung diseases on angina pectoris among Indian adults: longitudinal ageing study in India

  2024cites this paper
• High Prevalence of Unrecognized Actionable Cardiac Arrhythmias in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease

  2024cites this paper
• 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2023cites this paper
• Bisoprolol versus celiprolol on dynamic hyperinflation, cardiopulmonary exercise and domiciliary safety in COPD: a single-centre, randomised, crossover study

  2023cites this paper
• Efficacy and Safety of Bisoprolol in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis

  2023cites this paper
• Cardiovascular Prognosis of Subclinical Chronic Obstructive Pulmonary Disease in Patients with Suspected or Confirmed Coronary Artery Disease

  2023cites this paper
• Role of β-blockers in the cardiovascular disease continuum: a collaborative Delphi survey-based consensus from Asia-Pacific

  2023cites this paper
• Are beta-blockers safe and effective after myocardial infarction in patients with COPD?

  2023cites this paper
• Epidemiology and treatment of heart failure with chronic obstructive pulmonary disease in Canadian primary care

  2023cites this paper
• COPD‐X Australian guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2022 update

  2022cites this paper
• Cardioselective Versus Nonselective β-Blockers After Myocardial Infarction in Adults With Chronic Obstructive Pulmonary Disease.

  2022cites this paper
• Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)

  2022cites this paper
• To β-Block or Not to β-Block: That Is Still the Question in Chronic Obstructive Pulmonary Disease

  2022cites this paper
• Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics

  2022cites this paper
• Cardiovascular Medication Use and Risk of Acute Exacerbation in Patients With Asthma-COPD Overlap (CVACO Study)

  2022cites this paper
• Beta blockers in HF, reduced EF And Increased HR

  2022cites this paper
• Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction

  2021cites this paper
• Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison

  2021influential citation
• COPD and Cardiovascular Disease: A Review of Association, Interrelationship, and Basic Principles for Integrated Management.

  2021cites this paper
• Management of noncardiovascular comorbidities in patients with heart failure with reduced ejection fraction

  2021cites this paper
• Beta-Blockers in High-Risk Outpatients with Chronic Obstructive Pulmonary Disease are Associated with All-Cause Mortality – The STATUETTE Cohort Study

  2021cites this paper
• Preventing adverse cardiac events (PACE) in chronic obstructive pulmonary disease (COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of bisoprolol in COPD

  2021cites this paper
• The Impact of beta blockade on the cardio-respiratory system and symptoms during exercise

  2021cites this paper
• The use of beta-blockers in patients with chronic obstructive pulmonary disease and chronic heart failure in real clinical practice

  2021cites this paper
• Update on the Impact of Comorbidities on the Efficacy and Safety of Heart Failure Medications

  2021cites this paper
• SEMINAR FOR PHYSICIANS SEMINAR ZA LEKARE U PRAKSI USE OF BETA BLOCKERS IN PATIENTS WITH ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE

  2021cites this paper
• COPD_A_313498 2301..2322

  2021cites this paper
• Effect of β-blockers on the risk of COPD exacerbations according to indication of use: the Rotterdam Study

  2021cites this paper
• The use of β-blockers in patients with heart failure and comorbidities: Doubts, certainties and unsolved issues.

  2021cites this paper
• CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care

  2021cites this paper
• Relationship between heart failure and the risk of acute exacerbation of COPD

  2021cites this paper
• Lung function and cardiovascular disease: A link.

  2020cites this paper
• Screening for comorbidities in COPD

  2020cites this paper
• Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE (BRONCHIOLE) – Study protocol from a randomized controlled trial

  2020cites this paper
• Too little, too late? The underuse of beta‐blockers in COPD needs evidence to address clinical uncertainty

  2020cites this paper
• Acute exacerbation of chronic obstructive pulmonary disease Straight to the point of care

  2020cites this paper
• EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ NATIONAL SOCIETY OF HEART FAILURE AND MYOCARDIAL DISEASE (NSHFMD) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE (2020)

  2020cites this paper
• Factors Associated with Exercise-Induced Desaturation in Patients with Chronic Obstructive Pulmonary Disease

  2020cites this paper
• The bidirectional relationship between chronic obstructive pulmonary disease and coronary artery disease

  2020cites this paper
• Beta-blocker use and acute exacerbations of COPD following myocardial infarction: a Danish nationwide cohort study

  2020cites this paper
• Medication Safety in Chronic Lung Disease with Cardiac Comorbidity

  2020cites this paper
• A Review of Association, Interrelationship, and Basic Principles for Integrated Management

  2020cites this paper
• Хроническая сердечная недостаточность. Клинические рекомендации 2020

  2020cites this paper
• Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

  2020cites this paper
• Underuse of beta‐blockers by patients with COPD and co‐morbid acute coronary syndrome: A nationwide follow‐up study in New Zealand

  2020cites this paper
• Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis

  2020influential citation
• INTERACCIONES FARMACOLÓGICAS PARA ANCIANOS CON ENFERMEDADES RESPIRATORIAS Y TIEMPOS DE COVID-19: UNA REVISIÓN SISTEMÁTICA DEL ALCANCE

  2020cites this paper
• Beta-blockers in COPD: A systematic review based on recent research.

  2020cites this paper
• Beta Adrenergic Blocker Use in Patients With Chronic Obstructive Pulmonary Disease and Concurrent Chronic Heart Failure With a Low Ejection Fraction.

  2020cites this paper
• Japanese guidelines for adult asthma 2020.

  2020cites this paper
• COPD_A_242009 1015..1037

  2020cites this paper
• The impact of regular bisoprolol on the response to salbutamol in asthma: A double‐blind randomized placebo‐controlled crossover trial

  2020cites this paper
• What is the effect of beta-blocker use on lung function and mortality in patients with COPD?

  2020cites this paper
• Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease

  2020cites this paper
• Beta-blockers as Antiarrhythmic Agents

  2020cites this paper
• Management of the COPD Patient with Comorbidities: An Experts Recommendation Document

  2020cites this paper
• Computational evaluation on the molecular conformation, vibrational spectroscopy, NBO analysis and molecular docking of betaxolol and betaxolol-chlorthalidone cocrystals

  2020cites this paper
• Do healthy patients require treatment after a first GTC seizure?

  2020cites this paper
• Chronic obstructive pulmonary disease and chronic heart failure : particularities of co treatment

  2020cites this paper
• β-blockers: their new life from hypertension to cancer and migraine.

  2019cites this paper
• Study on prevalence of left ventricular diastolic dysfunction in chronic obstructive pulmonary disease

  2019cites this paper
• Who's Afraid of the Big Bad Wolf? Safety of Beta-Blockers in COPD

  2019cites this paper
• Acutely decompensated heart failure with chronic obstructive pulmonary disease: Clinical characteristics and long-term survival.

  2019cites this paper
• Angina and chronic obstructive pulmonary disease: facing the perfect storm

  2019cites this paper
• Coexisting chronic obstructive pulmonary disease and cardiovascular disease in clinical practice: a diagnostic and therapeutic challenge

  2019cites this paper
• A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population

  2019cites this paper
• Herat failure and chronic obstructive airway disease as combined comorbidities. Meta-analysis and Review

  2019cites this paper
• Metoprolol for the Prevention of Acute Exacerbations of COPD.

  2019cites this paper
• Beta-Blockers in COPD - A Controversy Resolved?

  2019cites this paper
• β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: A nationwide population-based observational study

  2019cites this paper
• Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.

  2019cites this paper
• Beta-blocker, aspirin and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in Denmark.

  2019cites this paper
• Острые формы ишемической болезни сердца при обострении хронической обструктивной болезни легких: эпидемиология, диагностика и лечение

  2019cites this paper
• Arterial hypertension and chronic obstructive pulmonary disease: clinical characteristics and treatment efficasy (according to the national register of arterial hypertension).

  2019cites this paper
• Improving outcomes in chronic obstructive pulmonary disease by taking beta-blockers after acute myocardial infarction: a nationwide observational study

  2019cites this paper
• The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5).

  2019cites this paper
• Rate control and clinical outcomes in patients with atrial fibrillation and obstructive lung disease.

  2018cites this paper
• &bgr;‐Blockers in COPD: A Cohort Study From the TONADO Research Program

  2018cites this paper
• Tolerability of Bisoprolol on Domiciliary Spirometry in COPD

  2018cites this paper
• Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases.

  2018cites this paper
• Effect of beta-blocker therapy on clinical outcomes, safety, health-related quality of life and functional capacity in patients with chronic obstructive pulmonary disease (COPD): a protocol for a systematic literature review and meta-analysis with multiple treatment comparison

  2018cites this paper
• Anesthetic Management of the Hypertensive Patient: Part II.

  2018cites this paper
• Ischemic Heart Disease during Acute Exacerbations of COPD

  2018cites this paper
• Starting beta‐blockers during exacerbations of chronic obstructive pulmonary disease

  2018cites this paper
• Use of beta‐blocker is associated with lower mortality in patients with coronary artery disease with or without COPD

  2018cites this paper
• Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Promising Medication for Chronic Obstructive Pulmonary Disease?

  2018cites this paper
• Cardiovascular disease and COPD: dangerous liaisons?

  2018cites this paper